Abstract
Mevalonate kinase deficiency (MKD) is caused by mutations in the MVK gene, encoding the second enzyme of mevalonate pathway, which results in subsequent shortage of downstream compounds, and starts in childhood with febrile attacks, skin, joint, and gastrointestinal symptoms, sometimes induced by vaccinations. For a history of early-onset corticosteroid-induced reduction of bone mineral density in a 14-year-old boy with MKD, who also had presented three bone fractures, we administered weekly oral alendronate, a drug widely used in the management of osteoporosis and other high bone turnover diseases, which blocks mevalonate and halts the prenylation process. All of the patient's MKD clinical and laboratory abnormalities were resolved after starting alendronate treatment. This observation appears enigmatic, since alendronate should reinforce the metabolic block characterizing MKD, but is crucial because of the ultimate improvement shown by this patient. The anti-inflammatory properties of bisphosphonates are a new question for debate among physicians across various specialties, and requires further biochemical and clinical investigation.
References
May 1, 1991·Postgraduate Medical Journal·R Topaloğlu, U Saatçi
Oct 1, 1986·Calcified Tissue International·S AdamiV Lo Cascio
Sep 1, 1987·Archives of Internal Medicine·G Attardo-ParrinelloE Ascari
May 19, 1984·Lancet·J W van der MeerR van Furth
Nov 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·P SansoniE G Engleman
Mar 7, 1998·Life Sciences·J MönkkönenM J Rogers
Oct 3, 2000·Arthritis and Rheumatism·P BarreraW B van den Berg
Feb 20, 2003·European Heart Journal·P O BonettiA Lerman
Mar 14, 2003·European Journal of Human Genetics : EJHG·Sander M HoutenHans R Waterham
Mar 24, 2004·Neurology·A SimonJ P H Drenth
Oct 6, 2005·Toxicology and Applied Pharmacology·Xue DengYasuo Endo
Nov 1, 2006·Arthritis and Rheumatism·Saskia H L MandeyHans R Waterham
Dec 2, 2006·Blood·Evelien J BodarAnna Simon
Feb 1, 2007·Arthritis and Rheumatism·Donato RiganteAchille Stabile
Feb 5, 2008·Molecular Immunology·Loes M KuijkJoost Frenkel
Apr 9, 2008·Pediatric Research·Annalisa MarcuzziAlessandro Ventura
Apr 15, 2008·Human Mutation·Florian MilhavetIsabelle Touitou
Nov 18, 2008·Medicine·Jeroen C H van der HilstUNKNOWN International HIDS Study Group
Sep 2, 2010·Toxicology Letters·Yosuke ShikamaYasuo Endo
Oct 12, 2010·Archives of Biochemistry and Biophysics·Henry M Miziorko
Jun 15, 2011·Apoptosis : an International Journal on Programmed Cell Death·Annalisa MarcuzziAlessandra Pontillo
Jul 4, 2012·Annals of the Rheumatic Diseases·Nienke Ter HaarUNKNOWN Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/Eurotraps Projects
Aug 2, 2012·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Valentina ZaninSergio Crovella
Aug 24, 2013·BioMed Research International·Donato RiganteLuca Cantarini
Citations
Jun 18, 2014·Clinical Rheumatology·Donato RiganteLuca Cantarini
Jun 23, 2015·Molecular Medicine Reports·Paola Maura TricaricoAnnalisa Marcuzzi
Jan 30, 2016·Indian Journal of Pediatrics·Ruth J Pepper, Helen J Lachmann
Jul 15, 2015·The Journal of Clinical Investigation·Neil E McCarthyAndrew J Stagg
May 21, 2015·Seminars in Immunopathology·C M Mulders-Manders, A Simon
Apr 3, 2015·Clinical Rheumatology·Vittoria BascheriniLuca Cantarini
Feb 28, 2015·European Journal of Pediatrics·Svetlana KostjukovitsMatti Korppi
Mar 19, 2015·Mediators of Inflammation·Giuseppe LopalcoDonato Rigante
Mar 13, 2014·Clinical Rheumatology·Giuseppe LopalcoLuca Cantarini
Jun 24, 2014·Clinical Rheumatology·Luca CantariniDonato Rigante
Sep 24, 2016·La Revue de médecine interne·C GaleottiI Koné-Paut
Jul 22, 2019·BMC Pediatrics·Tiziana CoppolaGabriela Maradiaga Panayotti